Download PDF
Thromb Haemost 1984; 51(01): 099-102
DOI: 10.1055/s-0038-1661030
Original Article
Schattauer GmbH Stuttgart

A Sequential Study of Plasma Histidine-Rich Glycoprotein and Plasminogen in Patients with Acute Myocardial Infarction and Deep Vein Thrombosis

Jørgen Jespersen
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, Esbjerg, and the Danish Institute for Clinical Epidemiology, Copenhagen, Denmark
,
Jørgen Gram
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, Esbjerg, and the Danish Institute for Clinical Epidemiology, Copenhagen, Denmark
,
Elsa Bach
The Section of Coagulation and Fibrinolysis, Department of Clinical Chemistry, Ribe County Hospital in Esbjerg, Esbjerg, and the Danish Institute for Clinical Epidemiology, Copenhagen, Denmark
› Author Affiliations
Further Information

Publication History

Received 22 September 1983

Accepted 01 December 1983

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

In a prospective study of deep vein thrombosis (DVT), detected by the Tc-plasmin test, in 34 patients with acute myocardial infarction sequential determinations were made in plasma by immunologic methods of histidine-rich glycoprotein (HRG) and total plasminogen and the concentrations of free plasminogen calculated. Mean plasma HRG concentrations were consistently higher in the group of patients, in which Tc-plasmin scanning had revealed the existence of DVT. The effect of HRG caused the level of free plasminogen to be only 50–60% of the level of total plasminogen. Fluctuations of HRG caused only minor changes in free plasminogen concentrations. Our data suggest that HRG acts as a weak, negative acute phase reactant.

Key Words

Histidine-rich glycoprotein - Plasminogen - Free plasminogen - Myocardial infarction - Deep vein thrombosis - 99mTc-plasmin scanning
 

  • References

  • 1 Jespersen J, Gram J, Christensen L, Astrup T. Detection of deep vein thrombosis following myocardial infarction by the technetium-99m- plasmin test. Nucl Med Commun 1983; 4: 194-203
    PubMedSearch in Google Scholar
  • 2 Murray TS, Lorimer AR, Cox FC, Lawrie TD V. Leg-vein thrombosis following myocardial infarction. Lancet 1970; 2: 792-793
    PubMedSearch in Google Scholar
  • 3 Maurer BJ, Wray R, Schillingford JP. Frequency of venous thrombosis after myocardial infarction. Lancet 1971; 2: 1385-1387
    PubMedSearch in Google Scholar
  • 4 Nicolaides AN, Kakkar VV, Renney JT Q, Kinder PH, Hutchison DC S, Clarke MB. Myocardial infarction and deep-vein thrombosis. Br Med J 1971; 1: 432-434
    CrossrefPubMedSearch in Google Scholar
  • 5 Astrup T, Jespersen J. Thrombosis, disseminated intravascular coagulation, and the dynamic haemostatic balance. Aspects of prophylaxis and treatment. Inter Angio (in press).
    PubMed
  • 6 Nilsson IM. Phenformin and ethylestrenol in recurrent venous thrombosis. In: Progress in chemical fibrinolysis and thrombosis. Davidson JF, Samama MM, Desnoyers PC. eds Raven Press; New York: 1975. pp 1-12
    Search in Google Scholar
  • 7 Heimburger N, Haupt H, Kranz T, Bauder S. Humanserumproteine mit hoher Affinität zu Carboxymethylcellulose. II. Physikalischchemische und immunologische Charakterisierung eines histidine- reichen 3.8 S-α2-Glycoproteins (CM-protein I). Hoppe-Seyler’s Z Physiol Chem 1972; 353: 1133-1140
    PubMedSearch in Google Scholar
  • 8 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of human plasma protein with affinity for lysine binding sites in plasminogen. J Biol Chem 1980; 225: 10214-10222
    PubMedSearch in Google Scholar
  • 9 Persson RB, Darte L. Labeling plasmin with technetium-99m for scintigraphic localization of thrombi. Int J Appl Radiat Isot 1977; 28: 97-104
    CrossrefPubMedSearch in Google Scholar
  • 10 Olsson CG, Albrechtsson U, Darte L, Persson RB R. Tc-99m-plasmin for rapid detection of deep vein thrombosis. Nucl Med Commun 1982; 3: 41-52
    CrossrefPubMedSearch in Google Scholar
  • 11 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-240
    CrossrefPubMedSearch in Google Scholar
  • 12 Jespersen J, Kluft C. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thromb Haemostas 1982; 48: 283-285
    PubMedSearch in Google Scholar
  • 13 Rákóczi I, Wiman B, Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta 1978; 540: 295-300
    CrossrefPubMedSearch in Google Scholar
  • 14 Aoki N, Moroi M, Tachiya K. Effects of α2-plasmin inhibitor on fibrin clot lysis. Its comparison with α2-macroglobulin Thromb Haemostas 1978; 39: 22-31
    PubMedSearch in Google Scholar
  • 15 Kluft C, Los N. Demonstration of two forms of α2-antiplasmin in plasma by modified crossed immunoelectrophoresis. Thromb Res 1981; 21: 65-71
    CrossrefPubMedSearch in Google Scholar
  • 16 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257: 2912-2919
    PubMedSearch in Google Scholar
  • 17 Neumeier D, Prellwitz W, Knedel M. Infarct size estimation from serial analyses of creatine kinase and isoenzyme activity. In: Lang H. (ed.) Creatine Kinase Isoenzymes. Pathophysiology and Clinical Application Springer-Verlag; New York: 1981. pp 155-156
    Search in Google Scholar
  • 18 Morgan WT, Koskelo P, Koenig H, Conway TP. Human histidine- rich glycoprotein. II. Serum levels in adults, pregnant women and neonates. Proc Soc Exp Biol Med 1978; 158: 647-651
    CrossrefPubMedSearch in Google Scholar
  • 19 Jespersen J, Kluft C. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Scand J Clin Lab Invest 1982; 42: 563-566
    CrossrefPubMedSearch in Google Scholar
  • 20 Lijnen HR, Jacobs G, Collen D. Histidine-rich glycoprotein in a normal and a clinical population. Thromb Res 1981; 22: 519-523
    CrossrefPubMedSearch in Google Scholar
  • 21 Saito H, Goodnough LT, Boyle JM, Heimburger N. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. JAMA 1982; 73: 179-182
    CrossrefPubMedSearch in Google Scholar
  • 22 Jespersen J. Sequential study of plasma euglobulipn fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen. Gynecol Obstet Invest 1983; 15: 266-274
    CrossrefPubMedSearch in Google Scholar
  • 23 Jespersen J, Sidelmann J. Individual levels of plasma α2-antiplasmin and α2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Thromb Haemostas 1983; 50: 581-585
    PubMedSearch in Google Scholar
  • 24 Van Oss CJ, Bronson PM, Border JR. Changes in the serum alpha glycoprotein distribution in trauma patients. J Trauma 1975; 15: 451-455
    CrossrefPubMedSearch in Google Scholar
  • 25 Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha2HS glycoprotein during the inflammatory process. J Clin Invest 1979; 64: 1118-1129
    CrossrefPubMedSearch in Google Scholar
  • 26 Lijnen HR, DeCock F, Collen D. Turnover of human histidine-rich glycoprotein in healthy subjects and during thrombolytic therapy. Thromb Res 1981; 23: 121-131
    CrossrefPubMedSearch in Google Scholar